In our international business, we focus on the European, American, and Asian markets, offering a range of OTC medications such as antipyretic analgesics, cold remedies, and topical anti-inflammatory pain relievers. We also provide drink supplements like "Lipovitan," as well as health foods and cosmetics, catering to the health and beauty needs of local consumers.
In our international business, we focus on the European, American, and Asian markets, offering a range of OTC medications such as antipyretic analgesics, cold remedies, and topical anti-inflammatory pain relievers. We also provide drink supplements like "Lipovitan," as well as health foods and cosmetics, catering to the health and beauty needs of local consumers.
Our international expansion began in 1963 with the launch of "Lipovitan" in Taiwan. In 2009, we made a significant entry into the OTC medication market in Asia. Since then, we have expanded our business by acquiring local OTC brands through mergers and acquisitions, strengthening our product portfolio and establishing a strong presence in the region.
Our international expansion began in 1963 with the launch of "Lipovitan" in Taiwan. In 2009, we made a significant entry into the OTC medication market in Asia. Since then, we have expanded our business by acquiring local OTC brands through mergers and acquisitions, strengthening our product portfolio and establishing a strong presence in the region.
1963 Lipovitan launched in Taiwan. Expansion of Lipovitan in Asia started
2009 Taisho Pharmaceutical acquired trademark rights to the OTC drugs owned by U.S. company
Bristol-Myers Squibb (BMS) in Asia and stock of PT Bristol-Myers Squibb Indonesia Tbk (BMSI)
[Full-scale expansion into Asia]
2019 Duoc Hau Giang Pharmaceutical JSC (Vietnam) and UPSA (France) became our subsidiaries
[Expansion into Europe]
1963 Lipovitan launched
in Taiwan. Expansion of
Lipovitan in Asia started
2009 Taisho Pharmaceutical
acquired trademark rights
to the OTC drugs owned
by U.S. company
Bristol-Myers Squibb
(BMS) in Asia and stock of
PT Bristol-Myers Squibb
Indonesia Tbk (BMSI)
[Full-scale expansion
into Asia]
2019 Duoc Hau Giang
Pharmaceutical JSC
(Vietnam) and UPSA
(France) became our
subsidiaries
[Expansion into Europe]
In 2019, we acquired Hau Giang Pharmaceutical in Vietnam and UPSA in France, establishing a dual business structure in Europe and Asia.
In 2019, we acquired Hau Giang Pharmaceutical in Vietnam and UPSA in France, establishing a dual business structure in Europe and Asia.
In addition to OTC medications and drink supplements, we offer a wide range of products including health foods and beauty supplements. We enhance our brand value by tailoring products to meet the specific needs of local consumers in each region.
This approach takes into account the varying regulations and commercial practices across different countries and regions, as well as the preference for locally established brands.
In addition to OTC medications and drink supplements, we offer a wide range of products including health foods and beauty supplements. We enhance our brand value by tailoring products to meet the specific needs of local consumers in each region.
This approach takes into account the varying regulations and commercial practices across different countries and regions, as well as the preference for locally established brands.
We offer brands that are cherished by local consumers across generations, even in our international markets.
We offer brands that are cherished by local consumers across generations, even in our international markets.
Efferalgan, an antipyretic analgesic
Efferalgan, an antipyretic analgesic
Dafalgan, an antipyretic analgesic
Dafalgan, an antipyretic analgesic
Tempra, an antipyretic analgesic
Tempra, an antipyretic analgesic
Hapacol, an antipyretic analgesic
Hapacol, an antipyretic analgesic
Counterpain, a topical anti-inflammatory analgesic
Counterpain, a topical anti-inflammatory analgesic
Lipovitan, an enegy drink
Lipovitan, an enegy drink
Currently, we are advancing the integration and unification of quality control, manufacturing management, and information management. At the same time, we are committed to further product development and brand nurturing, promoting the spread of self-medication to expand our business.
Currently, we are advancing the integration and unification of quality control, manufacturing management, and information management. At the same time, we are committed to further product development and brand nurturing, promoting the spread of self-medication to expand our business.
In 1963, a year after launching "Lipovitan D," we began exporting it to Taiwan, marking the start of our international expansion. Since then, we have actively promoted the "Lipovitan" brand, which has now become widely recognized in Asia, including Thailand, Malaysia, and the Philippines. We have also expanded to regions such as Bahrain in the Middle East and the United States.
Unlike the Japanese version, "Lipovitan" overseas is tailored to local preferences, available in cans, sweetened with honey, or even carbonated.
In 1963, a year after launching "Lipovitan D," we began exporting it to Taiwan, marking the start of our international expansion. Since then, we have actively promoted the "Lipovitan" brand, which has now become widely recognized in Asia, including Thailand, Malaysia, and the Philippines. We have also expanded to regions such as Bahrain in the Middle East and the United States.
Unlike the Japanese version, "Lipovitan" overseas is tailored to local preferences, available in cans, sweetened with honey, or even carbonated.